News Focus
News Focus
icon url

Brian903

07/08/18 1:06 PM

#84862 RE: DragonBear #84859

I like your advice of patient confidence...

bearspread Saturday, 01/27/18 04:13:22 PM
Re: bar1080 post# 131702 0
Post # of 137940

97% of professional investors read this; maybe 1% of IHUBers have...

I'm one of the 3%ers LOL!

invest with patient confidence

Right up to the moment until a material event crashes the stock. Ever been in a drug company that has a CT fail?
icon url

Brian903

07/08/18 1:53 PM

#84863 RE: DragonBear #84859

You said ...

Quote:The higher the assumed future growth rate, and the longer the time period



Wonder how huge growth over a short period of time works. Think startup biotechs, where one buys as they enter Phase 2 CT trials. Much more mustard!

The Jewel of the Mind is Colored with the Hue of what it Imagines
icon url

takeyouhigher

07/09/18 5:35 PM

#84881 RE: DragonBear #84859

You're exactly right. I noticed this presentation at ASCO as well.
It seems that standard gemcitabine/ plus nab-paclitaxel will no longer be standard of care. That means that PMCB's comparator arm in its make believe clinical trial will not be the standard treatment.
icon url

Brian903

07/09/18 11:13 PM

#84888 RE: DragonBear #84859

Site to visit and compare Armo to pmcb’s trial- anyone else notice the difference the bear it touting?
http://www.armobio.com/clinicaldevelopment-sequoia.php